Psilocybin therapy for cannabis use disorder
Treatments studied
Part of Mental health clinical trials.
This study tests if psilocybin (a substance that can change how you think and feel) can help people reduce or stop using cannabis. You will receive support and be monitored closely throughout the trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with cannabis use disorder (problematic cannabis use).
- You are medically healthy, based on a checkup and lab tests.
- If you take certain antidepressants (SSRIs, SNRIs, or bupropion), your dose must have been stable for at least 2 months.
- You do not have other serious substance use problems (except nicotine) in the past 5 years.
- You do not have certain heart conditions, kidney disease, or a history of psychosis or bipolar disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a treatment called repetitive transcranial magnetic stimulation (a non-surgical magnetic stimulation to the brain) can help people reduce or stop cannabis use. You may be eligible if you have cannabis use disorder and meet specific safety and symptom criteria.
This study tests whether a gentle brain stimulation technique (called tDCS) can help people who want to cut down or stop using cannabis. You'll wear a headband-like device during sessions at NYU, and the study team will check in with you over time.
This study tests whether adding a noninvasive brain stimulation technique (called tACS) to motivational interviewing—a type of counseling—can help people reduce their cannabis use. You will receive the brain stimulation during counseling sessions, and your progress will be monitored over several weeks.
This trial tests CBD as a potential treatment for heavy cannabis concentrate users who want to cut down or quit. You would take CBD daily and attend regular visits to track your progress.
This trial tests whether psilocybin can help people recovering from opioid use disorder while living at a residential treatment center. If you are already taking buprenorphine/naloxone (Suboxone), methadone, or have received Sublocade, this study may be an option for you.
This trial tests whether a single dose of psilocybin (a psychedelic compound) can help people with moderate to severe cannabis use disorder reduce or stop their cannabis use. You will receive the drug in a supervised setting and have follow-up check-ins.
Hear when a new Cannabis Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.